|
From Research to Practice - Lipid Management for Low HDL-Cholesterol Clinical Trials Info presented on Clinical Trials Search is not intended to be a substitute for certified medical advice, visits or professional assistance using a real physician. We are not physicians. Always consult your dr. about From Research to Practice - Lipid Management for Low HDL-Cholesterol conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. From Research to Practice - Lipid Management for Low HDL-Cholesterol Clinical research trials and From Research to Practice - Lipid Management for Low HDL-Cholesterol health trials happen in many of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new drugs. The function of the studies / projects is to resolve particular human medical questions. Clinical trials are a popular manner for mDs, government agencies, and private sector corporations to discover remedies for all varieties of circumstances, like From Research to Practice - Lipid Management for Low HDL-Cholesterol. From Research to Practice - Lipid Management for Low HDL-Cholesterol Clinical Trials and other clinical trials allow volunteers to obtain healthcare treatment options before they are available to the masses. Some times the participants undergo professional assistance for free of charge, and occasionally they are paid for their time. Sometimes there is a cost for a From Research to Practice - Lipid Management for Low HDL-Cholesterol clinical trial. Human subjects often get the best healthcare available for their From Research to Practice - Lipid Management for Low HDL-Cholesterol condition. Dangers are a reality, however, and may include additional or frequent mD visits, healthcare dangers (potentially life-jeopardising), and/or the treatment being ineffectual. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "F" Clinical Trials Conditions > From Research to Practice - Lipid Management for Low HDL-Cholesterol  From Research to Practice - Lipid Management for Low HDL-Cholesterol
From Research to Practice - Lipid Management for Low HDL-Cholesterol
For Condition: Coronary Heart Disease,Myocardial Ischemia
Status: No longer recruiting
Sponsor(s): Department of Veterans Affairs , Department of Veterans Affairs Health Services Research and Development Service
Synopsis: The overall purpose of this project is to improve the clinical outcomes of veterans with ischemic heart disease (IHD) through implementation of evidence-based lipid management, with a particular focus on veterans whose primary lipid abnormality is a low level of HDL-cholesterol (the “good” cholesterol). The major objectives are 1. to determine whether a multifaceted intervention results in improved guideline-concordant lipid management for patients with low HDL-cholesterol; and 2. to test the relative effectiveness of three different reminder systems on physician prescribing behavior. The primary care clinic at each of the six VISN 13 facilities will serve as intervention sites. Within those sites we will randomize providers to one of three reminder systems. Control sites will consist of twelve other facilities matched to the intervention sites on the basis of facility characteristics. We will use a modified “pre-post” nested cohort design that allows us to evaluate the effect of the intervention controlling for secular trends. Target patients will be identified based on the following: 1. an IHD diagnosis within the past 5 years; 2. regular follow-up in a primary care clinic; 3. most recent LDL-cholesterol less than 130 mg/dl and HDL-cholesterol less than 40 mg/dl; 4. No lipid therapy within prior 6 months. The intervention will consist of: a. an on-site interactive educational workshop for providers; b. reminders (either patient-directed mailed reminders, computer-chart reminders at the time of visit, or automatic consults); c. opinion leader recruitment and “activation”. The primary outcome is proportion of target patients receiving guideline-concordant therapy. For objective 1, the outcome will be compared between intervention and control sites. For objective 2, the outcome will be compared between the three groups randomized to the different reminder systems. In addition, providers will be surveyed with a written questionnaire to determine their reaction to the educational workshop and the different reminder systems.
Details:
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: - Subjects are primary care providers from participating VISN sites. - Patients whose medical records are utilized are selected via an algorithm.
Total Enrollment: 11700
Location and Contact Information:
VA Medical Center
Minneapolis, Minnesota, 55417
United States
VA Medical Center
Minneapolis, Minnesota, 55417
United States
Additional Information:
Study ID Numbers: TRX 01-083;
Study Start Date: October 2001
Record last reviewed: September 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00057044
Other Coronary Heart Disease Studies:
1. Long Term Effects of Enalapril and Losartan on Genetic Heart Disease
2. Multicenter Unsustained Tachycardia Trial (MUSTT)
3. Harvard Atherosclerosis Reversibility Project (HARP)
4. Nitric Oxide Inhalation Therapy to Relieve Chest Pain in Patients with Coronary Artery Disease
5. Cardio Vascu-Grow for treatment of coronary heart disease
Related Studies:
Other Coronary Heart Disease Clinical Trials
Other Minnesota Clinical Trials
Other Minneapolis Clinical Trials
From Research to Practice - Lipid Management for Low HDL-Cholesterol
|
|
|
|
|
|
|
|
